10.1002/chem.201703272
Chemistry - A European Journal
FULL PAPER
[1]
For recent reviews, see for example: a) Ajeet, A. K. Mishra, A. Kumar,
Am. J. Pharmacol. Sci. 2015, 3, 18; b) A. Kołaczek, I. Fusiarz, J.
Ławecka, D. Branowska, Chemik 2014, 68, 620; c) S. S. A. Shah, G.
Rivera, M. Ashfaq, Mini-Rev. Med. Chem. 2013, 13, 70.
Tetrahedron: Asymmetry 2005, 16, 3484; f) T. A. Khan, J. D. Scott, J. N.
Cumming (Merck Sharp & Dohme Corp.), WO 2014/150340, 2014.
[14] a) E. U. Jonsson, C. C. Bacon, C. R. Johnson, J. Am. Chem. Soc. 1971,
93, 5306; b) E. U. Jonsson, C. C. Bacon, C. R. Johnson, J. Am. Chem.
Soc. 1971, 93, 5308; c) C. R. Johnson, E. U. Jonsson, C. C. Bacon, J.
Org. Chem. 1979, 44, 2055; d) C. R. Johnson, A. Wambsgans, J. Org.
Chem. 1979, 44, 2278; e) S. G. Pyne, J. Org. Chem. 1986, 51, 81; f) K.
Okuma, T. Kolke, H. Ohta, J. Org. Chem. 1988, 53, 4190; g) M.
Harmata, Tetrahedron Lett. 1989, 30, 437; h) R. Kluge, H. Hocke, M.
Schulz, F. Schilke, Phosphorus, Sulfur Silicon Relat. Elem. 1999, 149,
179; i) M. Reggelin, B. Junker, Chem. – Eur. J. 2001, 7, 1232; j) O.
García Mancheño, C. Bolm, Beilstein J. Org. Chem. 2007, 3, 25; k) M.
F. Maldonado, F. Sehgelmeble, F. Bjarnemark, M. Svensson, J. Ahman,
P. I. Arvidsson, Tetrahedron 2012, 68, 7456; l) S. R. K. Battula, G. V.
Subbareddy, I. E. Chakravarthy, Tetrahedron Lett. 2014, 55, 517; m) E.
Langkopf, A. Blum (Boehringer Ingelheim International GMBH), WO
2016/023789, 2016.
[2]
P. K. Chinthakindi, T. Naicker, N. Thota, T. Govender, H. G. Kruger, P.
I. Arvidsson, Angew. Chem. Int. Ed. 2017, 56, 4100.
[3]
[4]
Y. Chen, J. Gibson, RSC Adv. 2015, 5, 4171.
a) C. R. Johnson, Aldrichimica Acta 1985, 18, 3; b) M. Reggelin, C. Zur,
Synthesis 2000, 1; c) U. Lücking, Angew. Chem. Int. Ed. 2013, 52,
9399; d) M. Frings, C. Bolm, A. Blum, C. Gnamm, Eur. J. Med. Chem.
2017, 126, 225; e) J. A. Sirvent, U. Lücking, ChemMedChem 2017, 12,
487.
[5]
[6]
a) G. Siemeister, U. Luecking, A. M. Wengner, P. Lienau, W. Steinke, C.
Schatz, D. Mumberg, K. Ziegelbauer, Mol. Cancer Ther. 2012, 11,
2265; b) U. Lücking, R. Jautelat, M. Krüger, T. Brumby, P. Lienau, M.
Schäfer, H. Briem, J. Schulze, A. Hillisch, A. Reichel, A. M. Wengner, G.
Siemeister, ChemMedChem 2013, 8, 1067.
a) A. Scholz, T. Oellerich, A. Hussain, S. Lindner, U. Luecking, A. O.
Walter, P. Ellinghaus, R. Valencia, F. von Nussbaum, D. Mumberg, M.
Brands, S. Ince, H. Serve, K. Ziegelbauer, Cancer Res. 2016, 76 (14
Suppl), Abstract nr 3022; DOI: 10.1158/1538-7445.AM2016-3022; b) A.
Scholz, U. Luecking, G. Siemeister, P. Lienau, U. Boemer, P.
Ellinghaus, A. O. Walter, R. Valencia, S. Ince, F. von Nussbaum, D.
Mumberg, M. Brands, K. Ziegelbauer, Cancer Res. 2015, 75 (15 Suppl),
Abstract nr DDT02-02; DOI: 10.1158/1538-7445.AM2015-DDT02-02; c)
U. Luecking, A. Scholz, P. Lienau, G. Siemeister, D. Kosemund, R.
Bohlmann, K. Eis, M. Gnoth, I. Terebesi, K. Meyer, K. Prelle, R.
Valencia, S. Ince, F. von Nussbaum, D. Mumberg, K. Ziegelbauer, B.
Klebl, A. Choidas, P. Nussbaumer, M. Baumann, C. Schultz-
Fademrecht, G. Ruehter, J. Eickhoff, M. Brands, Cancer Res. 2015, 75
(15 Suppl), Abstract nr 2828; DOI: 10.1158/1538-7445.AM2015-2828.
K. M. Foote, A. Lau, J. W. M. Nissink, Future Med. Chem. 2015, 7, 873.
U. T. Luecking, A. Scholz, D. Kosemund, R. Bohlmann, H. Briem, P.
Lienau, G. Siemeister, I. Terebesi, K. Meyer, K. Prelle, R. Valencia, S.
Ince, F. von Nussbaum, D. Mumberg, K. Ziegelbauer, M. Brands,
AACR Annual Meeting, Washington, D.C., April, 2017, MS.CH01.01
#984.
[15] a) E. S. Levchenko, A. V. Kirsanov, Zh. Obshch. Khim. 1960, 30, 1553;
b) E. S. Levchenko, I. E. Sheinkman, A. V. Kirsanov, Zh. Obshch. Khim.
1960, 30, 1941; c) W. Ried, J. Valentin, Justus Liebigs Ann. Chem.
1966, 699, 183; d) A. K. Roy, J. Am. Chem. Soc. 1993, 115, 2598.
[16] See references 3 and 14j, and references therein.
[17] J. Wen, H. Cheng, S. Dong, C. Bolm, Chem. – Eur. J. 2016, 22, 5547.
[18] J. A. Sirvent, D. Bierer, R. Webster, U. Lücking, Synthesis 2017, 49,
1024.
[19] See reference 4e, and references therein.
[20] M. Zenzola, R. Doran, L. Degennaro, R. Luisi, J. Bull, Angew. Chem.
Int. Ed. 2016, 55, 7203.
[21] For recent developments concerning the use of PhI(OAc)2 in the
synthesis of sulfoximines, see also: a) A. Tota, M. Zenzola, S. J.
Chawner, S. St. John-Campbell, C. Carlucci, G. Romanazzi, L.
Degennaro, J. A. Bull, R. Luisi, Chem. Commun. 2017, 53, 348; b) J.-F.
Lohier, T. Glachet, H. Marzag, A.-C. Gaumont, V. Reboul, Chem.
Commun. 2017, 53, 2064; c) Y. Xie, B. Zhou, S. Zhou, S. Zhou, W. Wei,
J. Liu, Y. Zhan, D. Cheng, M. Chen, Y. Li, B. Wang, X.-S. Xue, Z. Li,
ChemistrySelect 2017, 2, 1620.
[7]
[8]
[22] a) D. Leca, L. Fensterbank, E. Lacôte, M. Malacria, Org. Lett. 2002, 4,
4093; b) D. Leca, K. Song, M. Amatore, L. Fensterbank, E. Lacôte, M.
Malacria, Chem. – Eur. J. 2004, 10, 906; c) A. Felim, A. Toussaint, C. R.
Phillips, D. Leca, A. Vagstad, L. Fensterbank, E. Lacôte, M. Malacria,
Org. Lett. 2006, 8, 337.
[9]
A.-D. Steinkamp, L. Schmitt, X. Chen, K. Fietkau, R. Heise, J. M. Baron,
C. Bolm, Skin Pharmacol. Physiol. 2016, 29, 281.
[10] Y. Chen, C.-J. Aurell, A. Pettersen, R. J. Lewis, M. A. Hayes, M.
Lepistö, A. C. Jonson, H. Leek, L. Thunberg, ACS Med. Chem. Lett.
2017, 8, 672.
[23] a) K. K. Andersen, Tetrahedron Lett. 1962, 93; b) J. R. Fulton, L. M.
Kamara, S. C. Morton, G. J. Rowlands, Tetrahedron 2009, 65, 9134.
[24] For the assay description, see: E. H. Kerns, L. Di, Drug-like Properties:
Concepts, Structure Design and Methods, Elsevier Inc./Academic
Press, Burlington, MA, USA, 2008, pp. 353–356.
[11] E. S. Levchenko, N. Y. Derkach, A. V. Kirsanov, Zh. Obshch. Khim.
1962, 32, 1208.
[12] For a comprehensive review, see: E. S. Levchenko, L. N. Markovskii, Y.
G. Shermolovich, Russ. J. Org. Chem. 2000, 36, 143.
[13] a) E. S. Levchenko, N. Y. Derkach, A. V. Kirsanov, Zh. Obshch. Khim.
1960, 30, 1971; b) E. S. Levchenko, N. Y. Derkach, A. V. Kirsanov, Zh.
Obshch. Khim. 1961, 31, 1971; c) S. Tsushima, Y. Yamada, T. Onami,
K. Oshima, M. O. Chaney, N. D. Jones, J. K. Swartzendruber, Bull.
Chem. Soc. Jpn. 1989, 62, 1167; d) P. H. Di Chenna, F. Robert-Peillard,
P. Dauban, R. H. Dodd, Org. Lett. 2004, 6, 4503; e) C. Fruit, F. Robert-
Peillard, G. Bernardinelli, P. Müller, R. H. Dodd, P. Dauban,
[25] For the assay description, see: U. Lücking, P. Wasnaire, A. Scholz, P.
Lienau, G. Siemeister, C. Stegmann, U. Boemer, K. Zheng, P. Gao, G.
Chen, J. Xi (Bayer Pharma Aktiengesellschaft), WO 2015155197, 2015.
[26] For the assay description, see: D. J. Minick, J. H. Frenz, M. A. Patrick,
D. A. Brent, J. Med. Chem. 1988, 31, 1023.
This article is protected by copyright. All rights reserved.